Kiniksa Pharmaceuticals International, plc (KNSA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Kiniksa Pharmaceuticals International, plc (KNSA) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

KNSA Income Statement

Kiniksa Pharmaceuticals International, plc (KNSA) annual income statement — 10-year revenue, gross profit & net income history

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	243.6M	214.27M	202.13M	180.85M	156.8M	137.78M	122.54M	112.21M	108.63M	79.86M	83.39M	67.05M	71.47M	48.34M	61.88M	99.14M	26.97M	32.19M	18.75M	12.1M
Revenue Growth %	55.36%	55.51%	64.95%	61.17%	44.34%	72.54%	46.93%	67.37%	51.99%	65.18%	34.76%	-32.37%	164.99%	50.19%	230.14%	719.64%	250.1%	-	-	-
Cost of Goods Sold	111.64M	96.37M	91.1M	83.59M	71.02M	61.66M	66.17M	49.42M	42.45M	31.54M	26.76M	27.4M	22.75M	16.45M	14.23M	12.51M	9.8M	13.57M	3.87M	3.84M
COGS % of Revenue	45.83%	44.98%	45.07%	46.22%	45.29%	44.75%	54%	44.04%	39.08%	39.49%	32.09%	40.86%	31.82%	34.03%	23%	12.62%	36.32%	42.15%	20.63%	31.77%
Gross Profit	131.96M	117.89M	111.03M	97.26M	85.76M	76.13M	56.36M	62.8M	66.18M	48.32M	56.64M	39.65M	48.73M	31.89M	47.65M	86.63M	17.18M	18.62M	14.88M	8.25M
Gross Margin %	54.17%	55.02%	54.93%	53.78%	54.7%	55.25%	46%	55.96%	60.92%	60.51%	67.91%	59.14%	68.18%	65.97%	77%	87.38%	63.68%	57.85%	79.37%	68.23%
Gross Profit Growth %	53.86%	54.86%	96.99%	54.88%	29.6%	57.55%	-0.48%	58.39%	35.81%	51.52%	18.85%	-54.23%	183.71%	71.25%	220.29%	949.63%	306.8%	2208.95%	-	-
Operating Expenses	104.77M	88.63M	91.26M	73.24M	65.62M	62.85M	75.66M	72.46M	66.29M	64.86M	56.55M	50.58M	51.88M	43.09M	41.6M	40.21M	36.54M	41.94M	51.01M	38.92M
OpEx % of Revenue	43.01%	41.36%	45.15%	40.5%	41.85%	45.62%	61.75%	64.57%	61.03%	81.22%	67.82%	75.43%	72.59%	89.12%	67.23%	40.56%	135.48%	130.3%	272.12%	321.79%
Selling, General & Admin	63.87M	61.15M	56.77M	49.1M	46.86M	43.53M	40.53M	46.4M	42.4M	38.68M	36.74M	33.76M	28.41M	28.2M	27.21M	23.91M	23.09M	21.48M	22.74M	20.06M
SG&A % of Revenue	26.22%	28.54%	28.09%	27.15%	29.89%	31.59%	33.08%	41.35%	39.03%	48.44%	44.05%	50.36%	39.74%	58.34%	43.98%	24.11%	85.63%	66.74%	121.32%	165.83%
Research & Development	40.9M	27.48M	34.64M	24.14M	18.75M	19.32M	35.13M	26.06M	23.9M	26.18M	19.82M	16.81M	23.48M	14.88M	14.39M	16.31M	13.45M	20.46M	27.43M	18.86M
R&D % of Revenue	16.79%	12.82%	17.14%	13.35%	11.96%	14.03%	28.67%	23.22%	22%	32.78%	23.76%	25.08%	32.84%	30.79%	23.25%	16.45%	49.86%	63.56%	146.35%	155.96%
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	835K	0
Operating Income	27.19M	29.27M	19.77M	24.02M	20.16M	13.27M	-19.3M	-9.66M	-117K	-16.54M	81K	-10.93M	-3.15M	-11.2M	6.05M	46.41M	-19.37M	-23.32M	-36.13M	-30.67M
Operating Margin %	11.16%	13.66%	9.78%	13.28%	12.86%	9.63%	-15.75%	-8.61%	-0.11%	-20.71%	0.1%	-16.3%	-4.41%	-23.16%	9.77%	46.82%	-71.81%	-72.44%	-192.75%	-253.55%
Operating Income Growth %	34.89%	120.52%	202.43%	348.72%	17330.77%	180.23%	-23925.93%	11.61%	96.29%	-47.75%	-98.66%	-123.54%	83.72%	51.99%	116.74%	251.35%	52.24%	52.68%	31.7%	29.04%
EBITDA	27.67M	29.73M	20.23M	24.41M	20.52M	13.62M	-18.9M	-9.26M	313K	-16.08M	317K	-9.93M	-2.09M	-10.07M	7.13M	47.36M	-18.27M	-22.23M	-35.46M	-29.59M
EBITDA Margin %	11.36%	13.88%	10.01%	13.49%	13.09%	9.88%	-15.42%	-8.25%	0.29%	-20.13%	0.38%	-14.81%	-2.93%	-20.82%	11.52%	47.78%	-67.74%	-69.05%	-189.19%	-244.66%
EBITDA Growth %	34.84%	118.37%	207.07%	363.58%	6455.27%	184.7%	-6061.83%	6.74%	114.95%	-59.71%	-95.55%	-120.96%	88.55%	54.71%	120.1%	260.05%	53.79%	54.08%	32.23%	30.48%
D&A (Non-Cash Add-back)	472K	468K	467K	384K	358K	345K	400K	399K	430K	466K	236K	999K	1.06M	1.13M	1.08M	949K	1.1M	1.09M	668K	1.07M
EBIT	27.19M	32.68M	23.27M	27.16M	22.88M	15.56M	-16.98M	-7.2M	2.3M	-14.28M	2.45M	-8.5M	-1.24M	-9.36M	6.84M	46.73M	-19.27M	-23.29M	-36.05M	-30.66M
Net Interest Income	3.95M	3.41M	2.72M	3.14M	2.72M	2.29M	2.32M	2.46M	2.42M	0	537K	2.43M	1.92M	3.66M	794K	322K	103K	34K	77K	5K
Interest Income	3.95M	3.41M	2.72M	3.14M	2.72M	2.29M	2.32M	2.46M	2.42M	0	2.37M	2.43M	1.92M	3.66M	794K	322K	103K	34K	77K	5K
Interest Expense	0	0	0	0	0	0	0	0	0	0	1.83M	0	0	0	0	0	0	0	0	0
Other Income/Expense	3.95M	3.41M	3.5M	3.14M	2.72M	2.29M	2.32M	2.46M	2.42M	2.27M	2.37M	2.43M	1.92M	1.83M	794K	322K	103K	34K	77K	5K
Pretax Income	31.14M	32.68M	23.27M	27.16M	22.88M	15.56M	-16.98M	-7.2M	2.3M	-14.28M	2.45M	-8.5M	-1.24M	-9.36M	6.84M	46.73M	-19.27M	-23.29M	-36.05M	-30.66M
Pretax Margin %	12.79%	15.25%	11.51%	15.02%	14.59%	11.3%	-13.86%	-6.42%	2.12%	-17.88%	2.94%	-12.68%	-1.73%	-19.37%	11.05%	47.14%	-71.43%	-72.34%	-192.34%	-253.51%
Income Tax	5.71M	10.09M	9.07M	8.72M	5.04M	7.03M	-8.09M	5.49M	6.21M	3.43M	-22.79M	5.36M	-16.21M	2.91M	2.38M	-177.36M	716K	1.93M	279K	-118K
Effective Tax Rate %	18.34%	30.87%	38.98%	32.12%	22.05%	45.14%	47.65%	-76.27%	269.62%	-24.01%	-930.08%	-63.02%	1308.39%	-31.03%	34.79%	-379.5%	-3.72%	-8.27%	-0.77%	0.38%
Net Income	25.43M	22.59M	14.2M	18.43M	17.83M	8.54M	-8.89M	-12.69M	-3.91M	-17.7M	25.24M	-13.86M	14.97M	-12.27M	4.46M	224.09M	-19.98M	-25.21M	-36.33M	-30.54M
Net Margin %	10.44%	10.54%	7.02%	10.19%	11.37%	6.2%	-7.25%	-11.31%	-3.6%	-22.17%	30.26%	-20.66%	20.95%	-25.38%	7.21%	226.05%	-74.08%	-78.32%	-193.83%	-252.53%
Net Income Growth %	42.62%	164.57%	259.75%	245.24%	556.29%	148.23%	-135.22%	8.39%	-126.1%	-44.29%	465.73%	-106.18%	174.93%	51.33%	112.28%	833.67%	51.93%	49.05%	32.29%	30.32%
Net Income (Continuing)	25.43M	22.59M	14.2M	18.43M	17.83M	8.54M	-8.89M	-12.69M	-3.91M	-17.7M	25.24M	-13.86M	14.97M	-12.27M	4.46M	224.09M	-19.98M	-25.21M	-36.33M	-30.54M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.30	0.27	0.18	0.23	0.23	0.11	-0.12	-0.18	-0.06	-0.25	0.35	-0.20	0.21	-0.18	0.06	3.18	-0.29	-0.36	-0.53	-0.44
EPS Growth %	30.43%	145.45%	250%	227.78%	518.18%	144%	-134.29%	10%	-126.19%	-38.89%	460%	-106.29%	172.41%	50%	111.79%	822.73%	52.46%	50%	32.91%	33.33%
EPS (Basic)	0.33	0.30	0.19	0.25	0.24	0.12	-0.12	-0.18	-0.06	-0.25	0.36	-0.20	0.21	-0.18	0.06	3.23	-0.29	-0.36	-0.53	-0.44
Diluted Shares Outstanding	83.4M	82.41M	78.98M	78.03M	77.94M	76.15M	72.32M	71.73M	71M	70.63M	72.66M	70.19M	71.63M	69.75M	71.37M	70.55M	69.29M	69.14M	68.97M	68.66M
Basic Shares Outstanding	77.58M	76.52M	74.2M	73.61M	73.44M	72.65M	72.32M	71.73M	71M	70.63M	70.37M	70.19M	69.92M	69.75M	69.61M	69.45M	68.9M	69.14M	68.97M	68.66M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-